Trek Financial LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 76.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 973 shares of the healthcare conglomerate’s stock after purchasing an additional 422 shares during the quarter. Trek Financial LLC’s holdings in UnitedHealth Group were worth $460,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also added to or reduced their stakes in the business. BlackRock Inc. lifted its position in shares of UnitedHealth Group by 0.7% during the 1st quarter. BlackRock Inc. now owns 74,928,539 shares of the healthcare conglomerate’s stock valued at $35,410,478,000 after acquiring an additional 509,633 shares during the period. Wellington Management Group LLP boosted its position in shares of UnitedHealth Group by 0.6% during the 1st quarter. Wellington Management Group LLP now owns 24,079,140 shares of the healthcare conglomerate’s stock worth $11,379,561,000 after purchasing an additional 140,312 shares in the last quarter. Geode Capital Management LLC raised its stake in UnitedHealth Group by 1.5% during the 4th quarter. Geode Capital Management LLC now owns 16,858,436 shares of the healthcare conglomerate’s stock worth $8,921,651,000 after buying an additional 247,997 shares during the period. Morgan Stanley grew its stake in UnitedHealth Group by 13.8% in the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock valued at $8,289,386,000 after acquiring an additional 1,893,192 shares during the period. Finally, Moneta Group Investment Advisors LLC raised its position in shares of UnitedHealth Group by 100,076.4% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after purchasing an additional 11,812,017 shares during the period. 85.69% of the stock is currently owned by institutional investors.
UnitedHealth Group Stock Performance
Shares of UNH opened at $480.77 on Monday. The stock’s 50-day simple moving average is $491.01 and its 200 day simple moving average is $486.73. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.80 and a current ratio of 0.80. UnitedHealth Group Incorporated has a 52-week low of $445.68 and a 52-week high of $558.10. The stock has a market capitalization of $445.34 billion, a price-to-earnings ratio of 21.51, a price-to-earnings-growth ratio of 1.43 and a beta of 0.66.
UnitedHealth Group Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Monday, September 11th will be issued a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.56%. The ex-dividend date is Friday, September 8th. UnitedHealth Group’s payout ratio is currently 33.65%.
Insiders Place Their Bets
In other news, CEO Andrew Witty sold 4,000 shares of the company’s stock in a transaction on Wednesday, July 19th. The shares were sold at an average price of $506.19, for a total value of $2,024,760.00. Following the completion of the sale, the chief executive officer now owns 78,573 shares of the company’s stock, valued at approximately $39,772,866.87. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.35% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
A number of equities research analysts recently commented on the company. Royal Bank of Canada lowered their price target on UnitedHealth Group from $592.00 to $572.00 and set an “outperform” rating for the company in a research report on Monday, July 17th. StockNews.com initiated coverage on shares of UnitedHealth Group in a research report on Thursday, August 17th. They issued a “buy” rating for the company. Piper Sandler began coverage on UnitedHealth Group in a research note on Thursday, May 25th. They issued an “overweight” rating and a $580.00 target price on the stock. Sanford C. Bernstein raised UnitedHealth Group from a “market perform” rating to an “outperform” rating and boosted their price objective for the stock from $595.00 to $603.00 in a research report on Tuesday, July 18th. Finally, Wells Fargo & Company lowered their target price on UnitedHealth Group from $616.00 to $561.00 in a research note on Thursday, July 13th. Two equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $575.65.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
- Five stocks we like better than UnitedHealth Group
- Your Comprehensive Guide to Investing in Bank Stocks
- MarketBeat Week in Review – 9/4 – 9/8
- How to Invest in Apparel Stocks
- The Best 5 Small Cap AI Companies to Buy Now
- What is the Shanghai Stock Exchange Composite Index?
- Miso Robotics Stock: Is an IPO Coming Soon?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.